AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
TROX

Tronox Holdings plc Ordinary Shares (UK) (TROX) fair value

Basic Materials · Chemicals · NYSE · United States
$3.46-0.57%
Market cap $553MNext earnings 2026-11-04Updated Oct 18, 2026
Add earnings to calendarGoogle
Our verdict
Trades 82% below our fair value
Price
$3.46
Model fair valueConfidence: low
about $19.14
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionTronox Holdings plc Ordinary Shares (UK) (TROX)
Fair value (2 models)
Not available
ACCE price target
$3.15
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $3.46 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
42
out of 100
Analysts
13% buy
8 covering
1-year return
-7.2%
Dividend yield
5.75%

Tronox Holdings plc Ordinary Shares (UK) in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Tronox makes titanium dioxide pigment, the white opacifier used in paints, coatings, plastics and paper, and it also produces zircon and other mineral sands from its own mines. The structural case rests on that vertical integration: owning the ilmenite and zircon feedstock insulates it somewhat from the raw-material squeeze that hits pigment producers without mines. The near-term driver is cyclical recovery in TiO2 pricing and volumes, which the 18.7% revenue growth suggests is underway, though the business is still unprofitable at the operating line with a 5.6% gross margin and a -2.0% operating margin. The stock trades at a forward P/E of 21.8 against a trailing figure that is zero because earnings are negative, so the multiple depends entirely on margins turning positive. With a market cap of about $554M, a 42/100 score, no index membership and a -41.3% ROE, this is a small, distressed-looking cyclical that merits a deeper look only if you have a view on TiO2 pricing and the balance sheet.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • severe
    Negative free cash flow
    Free cash flow is $-281M against a $554M market cap, so the business is burning cash faster than it earns. Debt/Equity of 2.53 leaves little room to absorb this.
  • high
    Leverage and negative returns
    Debt/Equity of 2.53 alongside ROE of -41.3% and net margin of -19.2% means losses are eroding equity while debt stays high.
  • moderate
    Price above ACCE target
    The stock trades 9.8% above the ACCE price target of $3.15, with the current price at $3.46.

AI research notes

AI-assisted·How I use AIWritten Oct 20, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 18.7% over the last year, far above its 0.9% average yearly pace over five years.
  • Analysts' mean price target of $5.50 sits 63.2% above the current share price.
  • The shares yield 5.7% in dividends, a meaningful cash return while the stock is under pressure.
Why it could disappoint
  • Net margin of -19.2% and free cash flow of -$281M show the business is losing money and burning cash.
  • Only 1 of 8 analysts rates the stock Buy or Strong Buy, and the latest quarterly earnings missed expectations by 30.8%.
  • Debt is 2.53 times equity, and return on equity of -41.3% leaves little cushion if conditions worsen.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where TROX's valuation models land
Price
$3.46
Model fair valueConfidence: low
about $19.14
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish13% buy · 8 covering analysts
● Strong buy 1● Buy 0● Hold 4● Sell 1● Strong sell 2
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-0.3%
1 month
-19.5%
3 months
-44.6%
6 months
-65.8%
YTD
-17.0%
1 year
-7.2%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$3.15first publication$3.50
9 Oct 2026, 00:00 CESTFair value$2.65$2.69$3.71
6 Oct 2026, 00:00 CESTFair value$2.69$2.73$3.93
26 Sept 2026, 00:00 CESTFair value$2.73$2.89$4.03
23 Sept 2026, 00:00 CESTFair value$2.89$2.83$4.31
21 Sept 2026, 00:00 CESTFair value$2.83$2.87$4.21
18 Sept 2026, 00:00 CESTFair value$2.87$2.91$4.29
13 Sept 2026, 00:00 CESTFair value$2.91$3.13$4.42
5 Sept 2026, 00:00 CESTFair value$3.13$3.36$4.88
30 Aug 2026, 00:00 CESTFair value$3.36first publication$5.40

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full TROX page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth88Value37Quality17Momentum25Total42
Valuation
Trailing P/E
no data
Forward P/E
-7.6x
PEG
no data
P/B
0.61x
EV / Revenue
1.3x
Book value/sh
$7.27
Enterprise value
$3.9B
Profitability
ROE
-41.3%
FCF yield
-50.85%
ROIC
-7.7%
Health and risk
Debt / equity
2.53
Dividend yield
5.75%
Beta
0.90

Price

-9.7% · 1Y

Ask anything about TROX

Answered from Tronox Holdings plc Ordinary Shares (UK) fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 33% of peers
low -549%-41%high 7%
Div yieldbetter than 100% of peers
low 0.0%5.8%high 5.8%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
TROX Tronox Holdings plc Ordinary Shares (UK)$3.46----41.3%1742
SGL.DE SGL Carbon SE€4.89€344% above--7.1%4045
RYAM Rayonier Advanced Materials Inc. Common Stock$6.70----49.7%1735
LXU LSB Industries Inc. Common Stock$9.89$826% above19.5x7.1%3845
ASIX AdvanSix Inc. Common Stock $15.71$3453% below--2.2%2726
VHI Valhi Inc. Common Stock$14.32----3.0%3248
BAK Braskem SA ADR$1.70----548.8%2649

Sector report card

Where TROX ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Oct 5, 2026
    Tronox Announces Dates for Third Quarter 2026 Earnings Release & Webcast Conference Call
  • PR Newswire•Sep 29, 2026
    Tronox Announces Signing of a Cooperation and Investment Agreement with JX Advanced Metals to Advance Rare Earth Strategy
  • PR Newswire•Aug 5, 2026
    Tronox Reports Second Quarter 2026 Financial Results
4 more press releases · full archive on Investor+.INVESTOR
34 filings
August 2026
Aug 6
8-KCurrent reportPeriod 2026-08-05
View on SEC →
Aug 6
10-QQuarterly reportPeriod 2026-06-30
View on SEC →
July 2026
Jul 31
Form 4Insider transactionPeriod 2026-07-29
View on SEC →
31 more filings + AI summaries on Investor+.INVESTOR